Pharmaceutical Excipients Market - Improving Excipient Capabilities using Nanotechnology
Overview of This Study:
This study involved four major activities in estimating the current size of the Pharmaceutical Excipients Market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the pharmaceutical excipients market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
# The key players in the industry and market have been identified through extensive secondary research
# The revenues generated from the pharmaceutical excipients business of leading players have been determined through primary and secondary research
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation:
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=956
Major Growth Driving Factors:
The rapidly growing pharmaceuticals market coupled with rise in generics production is driving the market growth for pharmaceutical excipients. However, the increasing regulatory stringency regarding the approval of drugs and excipients, along with the cost and time-intensive drug development process, are expected to restrain the growth of this market.
Expected Revenue Gains:
The pharmaceutical excipients market is projected to reach USD 11.5 billion by 2027 from USD 8.6 billion in 2022, at a CAGR of 5.9% during the forecast period.
How growth of generics closely related to the growth of pharmaceutical excipients?
According to industry experts, generic erosion is expected to result in significant revenue and volume losses for the branded drugs industry. This will enable the entry of cheaper generic counterparts into the market, which will boost the volume of drugs sold. The growing affordability and increasing healthcare expenditure in emerging economies will also drive the sales volume of generics in the forecast period. This is considered as a positive indicator of the growth of the pharmaceutical excipients market.
Why is cost and time-intensive drug development process a restraining factor that is holding back growth of market?
According to the California Biomedical Research Association (CBRA), it takes 12 years for a drug to travel from the research lab to the patient, including 1–6 years for toxicology studies alone. Moreover, late-stage failures in the drug development process also impact the time and cost associated with drug development. Although excipient and drug production has seen significant advances in recent years, the requirement for high capital investments is expected to hamper market growth during the forecast period
What opportunities does increase in multifunctional excipients open up for companies?
The development of excipients capable of multiple functions is considered a novel solution to counter the high time and cost requirements for bringing a drug to the market, a process that may take, on average, 10–12 years. Multifunctional excipients enhance the drug manufacturing process and improve flowability, compressibility, bioavailability, and particle size distribution. Thus producing lucrative growth opportunities.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=956
Europe was the largest regional market for Pharmaceutical Excipients Market in 2021.
The market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, Europe accounted for the largest share of the market. The large share of this region can be attributed to the presence of many pharmaceutical giants with large production capacities leading to high consumption of excipients. The growing emphasis on superior pharmaceutical products, generics, and biosimilars has also led to the increasing demand for novel excipients, which, in turn, is expected to drive market growth.